Bristol-Myers Squibb Company announced a regular quarterly dividend of $0.38, a 3 percent increase from the prior rate of $0.37 per share. The dividend will be paid at the new higher rate on February 1, 2016, to shareholders of record at close of business on January 4, 2016.
Analysis of Valuation of Bristol-Myers Squibb (Symbol BMY).
Bristol-Myers Squibb is trading above its average price/sale (P/S) range. Bristol-Myers Squibb is trading below its average historical dividend yield.
|Price 12/9/15||% Yield||5 Year Div. Growth Rate||SPS 2015||P/S Ratio||10 yr P/S Low||10 yr P/S High||5 yr max Yield %||5 yr lowest Yield %|
Explanation: Dividend growth stocks may be valued upon historical relative price/sales and current yield analysis. Dividend stocks trading at a low historical price/sales (P/S) ratio should be viewed more highly to investors due to their depressed valuation versus other higher P/S ratio stocks. Max P/S price target is based upon company reaching its highest historical P/S ratio. Dividend stocks should also be viewed favorably when the current yield is above historical readings for the past 10 years.
Further information on evaluating dividend growth candidates can be found at http://seekingalpha.com/author/timothy-mcintosh/articles